1 |
Gopalswamy N, Stelling HP, Markert RJ, et al (1994). A comparative study of eight fecal occult blood tests and HemoQuant in patients in whom colonoscopy is indicated. Arch Fam Med, 3, 1043-8.
DOI
|
2 |
Greenberg PD, Bertario L, Gnauck R, et al (2000). A prospective multicenter evaluation of new fecal occult blood tests in patients undergoing colonoscopy. Am J Gastroenterol, 95, 1331-8.
DOI
|
3 |
Greenlee RT, Hill-Harmon MB, Murray T, Bolden S, Wingo PA (2001). Cancer statistics. CA Cancer J Clin, 51, 15-36.
DOI
|
4 |
Hardcastle JD, Thomas WM, Chamberlain J, et al (1989). Randomised controlled trial of faecal occult blood screening for colorectal cancer: Results for first 107,349 Subjects. Lancet, 333, 1160-4.
DOI
|
5 |
Hardcastle JD, Robinson MH, Moss SM, et al (1996). Randomised controlled trial of faecaloccult-blood screening for colorectal cancer. Lancet, 348, 1472-1477.
DOI
|
6 |
Kong CK, RoslaniAC, Law CW, Law SKD, Arumugam K (2010). Impact of socio-economic class on colorectal cancer patient outcomes in Kuala Lumpur and Kuching, Malaysia. Asian Pacific J Cancer Prev, 11, 969-74.
|
7 |
Kronborg O, Fenger C, Worm J, et al (1996). Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet, 348, 1467-71.
DOI
|
8 |
Landis SH, Murray T, Bolden S,Wingo PA (1998). Cancer statistics, 1998. CA Cancer J Clin, 48, 6-2 9.
DOI
|
9 |
Levi, Z., Rozen, et al (2007). A quantitative immunochemical fecal occult blood test for colorectal neoplasia. Ann Int Med, 146, 244-55.
DOI
|
10 |
Allison JE, Tekawa IS, Ransom LJ, Adrain AL (1996). A comparison of fecal occult-blood tests for colorectal-cancer screening. New Engl J Med, 334, 155-9.
DOI
|
11 |
Ciccolallo L, Capocaccia R, Coleman MP, et al (2005). Survival differences between European and US patients with colorectal cancer: role of stage at diagnosis and surgery, Gut, 54, 268-73.
DOI
|
12 |
Cole SR, Young GP, Esterman A, Cadd B, Morcom J (2003). A randomised trial of the impact of new faecal haemoglobin test technologies on population participation in screening for colorectal cancer. J Med Screen, 10, 117-22.
DOI
|
13 |
Collins JF, Lieberman DA, Durbin TE, et al (2005). Accuracy of screening for fecal occult blood on a single stool sample obtained by digital rectal examination: a comparison with recommended sampling practice. Ann Int Med, 142, 81-85.
DOI
|
14 |
Silverman AL, Desai TK, Dhar R (1988). Clinical features, evaluation, and detection of colorectal cancer. Gastroenterol Clin North Am, 17, 713-725.
|
15 |
Mandel JS, Bond JS, Church TR, et al (1993). Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med, 328, 1365-71.
DOI
|
16 |
Ministry of Health Malaysia. (2006). Malaysia Cancer Staistics, Extracted from http://www.moh.gov.
|
17 |
Morikawa, T, Kato J, Yamaji Y, et al (2005). A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population. Gastroenterology, 129, 422-8.
DOI
|
18 |
Gatta G, Ciccolallo L, Capocaccia R, et al (2003). Differences in colorectal cancer survival between European and Us Populations: the importance of sub-site and morphology. Eur J Cancer, 39, 2214-22.
DOI
|
19 |
Espey DK, Wu XC, Swan J, et al (2007). Annual report to the nation on the status of cancer, 1975-2004, featuring cancer in American Indians and Alaska natives. Cancer, 110, 2119-52.
DOI
|